Related Experiment Videos
[Late myelopathy caused by ionizing radiation. Considerations on 3 cases]
Rivista Di Patologia Nervosa E Mentale
|May 1, 1984
Summary
Tardive myelopathy, a rare radiation side effect, was observed in patients treated with X-rays for tumors. While radiation dose is a primary factor, individual hypersensitivity can also contribute to this iatrogenic disorder.
Area of Science:
- Radiology
- Neurology
- Oncology
Background:
- X-ray therapy has been a cornerstone in tumor treatment.
- Radiation-induced neurological complications, though rare, are a concern.
- Understanding the risk factors for tardive myelopathy is crucial for patient safety.
Observation:
- Three cases of tardive myelopathy were identified in over 1000 patients treated with X-rays for tumors between 1974-1983.
- Two patients presented with a partial Brown-Séquard syndrome.
- One patient exhibited symptoms consistent with transverse myelitis.
Findings:
- Myelopathy in two patients was linked to radiation doses near the tolerance limit.
- The third patient's myelopathy suggested additional factors, possibly individual hypersensitivity of connective vascular tissue.
- These findings highlight the multifactorial nature of radiation-induced myelopathy.
Implications:
- Despite advancements in radiation safety, tardive myelopathy remains a potential iatrogenic risk.
- This underscores the importance of monitoring neurological function in patients receiving radiotherapy.
- Further research into individual patient factors influencing radiation sensitivity is warranted.